TrialGut and liver2022

Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of

Yoon Jin Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.